Target
E3 ubiquitin-protein ligase Mdm2
Ligand
BDBM50448931
Substrate
n/a
Meas. Tech.
ChEMBL_1296787 (CHEMBL3132470)
IC50
0.300000±n/a nM
Citation
 Sun, DLi, ZRew, YGribble, MBartberger, MDBeck, HPCanon, JChen, AChen, XChow, DDeignan, JDuquette, JEksterowicz, JFisher, BFox, BMFu, JGonzalez, AZGonzalez-Lopez De Turiso, FHouze, JBHuang, XJiang, MJin, LKayser, FLiu, JJLo, MCLong, AMLucas, BMcGee, LRMcIntosh, JMihalic, JOliner, JDOsgood, TPeterson, MLRoveto, PSaiki, AYShaffer, PToteva, MWang, YWang, YCWortman, SYakowec, PYan, XYe, QYu, DYu, MZhao, XZhou, JZhu, JOlson, SHMedina, JC Discovery of AMG 232, a potent, selective, and orally bioavailable MDM2-p53 inhibitor in clinical development. J Med Chem 57:1454-72 (2014) [PubMed]  Article 
Target
Name:
E3 ubiquitin-protein ligase Mdm2
Synonyms:
Double minute 2 protein | Double minute 2 protein (HDM2) | E3 ubiquitin-protein ligase Mdm2 (p53-binding protein Mdm2) | Hdm2 | Human Double Minute 2 (HDM2) | MDM2 | MDM2-MDMX | MDM2_HUMAN | p53-Binding Protein MDM2 | p53-binding protein
Type:
Oncoprotein
Mol. Mass.:
55196.54
Organism:
Homo sapiens (Human)
Description:
Q00987
Residue:
491
Sequence:
MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP
  
Inhibitor
Name:
BDBM50448931
Synonyms:
CHEMBL3125532
Type:
Small organic molecule
Emp. Form.:
C30H31Cl2NO5S
Mol. Mass.:
588.542
SMILES:
CC[C@@H](CS(=O)(=O)c1ccccc1)N1[C@@H]([C@H](C[C@](C)(CC(O)=O)C1=O)c1cccc(Cl)c1)c1ccc(Cl)cc1 |r|
Structure:
Search PDB for entries with ligand similarity: